Learn about INLYTA® (axitinib), an Rx option for the treatment of patients with advanced renal cell carcinoma (RCC). See risks & benefits.

Find tips to help manage certain side effects of INLYTA® (axitinib). See risks & benefits.

Find info on renal cell carcinoma, the most common type of kidney cancer. Learn how it starts, spreads and about the 4 stages of RCC. See risks & benefits.

Find helpful tips for taking INLYTA® (axitinib), an Rx option for advanced RCC when 1 prior drug treatment regimen has not worked. See risks & benefits.

Jan 27, 2012 · INLYTA clinical trial results In a head-to-head clinical trial, researchers studied progression-free survival (PFS) in 361 patients taking INLYTA versus 362 patients taking Nexavar® …

How INLYTA helps fight tumors Animal and laboratory studies suggest that INLYTA prevents new blood vessels from forming. It is believed that this may help stop tumors from growing and cancer from …

Learn about financial support options for INLYTA® (axitinib), including a co-pay card, on the official INLYTA® patient website. See risks & benefits.

Find helpful tips for taking INLYTA® (axitinib) with pembrolizumab for the first-line treatment of advanced renal cell carcinoma. See risks & benefits.

INLYTA in combination with pembrolizumab may cause your blood pressure to rise. In a clinical trial of INLYTA alone, hypertension occurred as early as 4 days into treatment. On average, this increase …

INLYTA® (axitinib) may cause serious side efects, including: High blood pressure (hypertension). High blood pressure is common with INLYTA and may sometimes be severe. Your healthcare provider …